Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering

Kyverna Therapeutics, Inc. announced the pricing of its upsized initial public offering of 14,500,000 shares of its common stock at an initial public offering price of $22.00 per share.

Scroll to Top